This inventor holds 2 USPTO granted patents. Top assignee: Enzon, Inc.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Myung-ok Park-Cho: Innovator in Interferon Polymer Conjugates
Introduction
Myung-ok Park-Cho is a notable inventor based in Seoul, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of interferon polymer conjugates. With a total of 2 patents, her work has the potential to impact therapeutic applications significantly.
Latest Patents
Myung-ok Park-Cho's latest patents focus on compositions containing alpha interferon conjugated to a substantially non-antigenic polymer. These compositions are designed so that at least about 30% of the conjugates include covalent attachment of the alpha interferon to the polymer at a histidine. The patents also disclose a process for preparing these conjugates, which involves contacting an alpha interferon with a succinimidyl carbonate-activated polymer at a pH that facilitates covalent attachment.
Career Highlights
Myung-ok Park-Cho is currently associated with Enzon, Inc., where she continues her innovative work in biotechnology. Her research has garnered attention for its potential applications in medical treatments.
Collaborations
Myung-ok collaborates with Carl W. Gilbert, contributing to the advancement of their shared research interests.
Conclusion
Myung-ok Park-Cho's contributions to the field of biotechnology, particularly through her patents on interferon polymer conjugates, highlight her role as an influential inventor. Her work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile